We demonstrated that TGF‐β treatment induced a significant increase in EGFR expression in breast cancer cells, and EGFR was essential for TGF‐β‐induced enhancement of the migration and invasion abilities of breast cancer cells. This evidence concerns the gene EGFR and breast carcinoma.